This review has two main strengths
The early numbers are impressive, but "better" depends on tolerability, safety, and what you personally need
A gap might be an unclear product form, a COA that does not match the lot, a missing method description, or supplier copy that conflicts with RUO positioning
You can use the website Safe Pharmacy to check
NAD+ injections avoid digestive slowdown, deliver NAD+ directly where cells can use it, and reduce variability day-to-day
The STEP trials demonstrated that semaglutide produces an average 15% body weight reduction over 68 weeks in patients with obesity, with some individuals losing up to 22% of their starting weight